Expanding diagnostics company secures £1.5m investment
A York-based diagnostics company is targeting further growth after securing a £1.5m investment from NPIF - Mercia Equity Finance.
Abingdon Health specialises in ‘point of care’ tests, to diagnose disease in humans, animals and plants and to measure drugs, hormones and other biomarkers in a range of sample types.
These single use devices allow testing to be carried out on site, in the field or at home and the results are interpreted by eye or using smartphone apps and reader devices.
Abingdon develops and manufactures tes... For the full story register now for free or login below...